IRAK1 and diffuse large B-cell lymphoma: Other mutations downstream of BTK and interleukin-1 receptor-associated kinase (IRAK) induce nuclear factor kB (NF-kB) activation and resemble those found in diffuse large B-cell lymphoma (41).